Athersys, Inc. is a biotech company specializing in regenerative medicine to treat neurological, cardiovascular, inflammatory, immune, and pulmonary diseases. Its primary product is MultiStem cell therapy currently undergoing clinical studies for patients suffering from neurological and respiratory distress, trauma complications, and other unmet medical needs. Athersys, Inc. also collaborates with other companies and institutions to develop and commercialize the MultiStem cell therapy platform.